As more states go for marijuana legalization, advocates see signs suggesting Texas too may move that way. This post from The Texas Tribune highlights the reasons for optimism in Texas. In Texas, both political parties now support loosening the restrictions on marijuana in their platforms. That's just the clearest sign that both public opinion and the political calculus on pot ... Continue Reading
Marijuana Legalization
Has This NY Report Paved the Way to Legal Cannabis?
In a recent 75-page assessment report, the New York State Health officials have shown the way to legal cannabis. This post from Leafly highlights the surprising conclusions. One of the nation’s most powerful, prosperous, and populous states is laying the groundwork to end cannabis prohibition. On Friday, July 13, New York State Health Commissioner Howard Zucker released a ... Continue Reading
New York Govt Study Favors Cannabis Legalization
The effort to legalize cannabis in New York received a huge boost when a state-conducted study had favorable things to say about cannabis legalization. This post from Green Flower shares the story in more detail. Momentum for cannabis legalization in New York State has never been greater, and efforts to make legalization a reality there received a huge boost last ... Continue Reading
Senate Panel Criticizes Cannabis’ Schedule 1 Barrier
A key U.S. Senate committee says that cannabis' current federal classification of schedule 1 blocks scientific research on its effects. But despite the seeming concern about the effect of state legalization, the panel's criticism of Schedule I's roadblocks to marijuana research provides more momentum to the effort to reclassify cannabis under federal law. This post from Forbes, ... Continue Reading
This FDA Approval Can Revamp Federal Cannabis Policy
The FDA approval of a CBD prescription drug just opened the door to transforming the marijuana policy. This article from The Washington Post, written by John Hudak, discusses how this approval can start a new policy conversation. The Food and Drug Administration did something entirely routine and completely unprecedented Monday: It approved a drug called Epidiolex. What makes ... Continue Reading